363 related articles for article (PubMed ID: 15603251)
1. Antisense and RNA interference approaches to target validation in pain research.
Kurreck J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):179-87. PubMed ID: 15603251
[TBL] [Abstract][Full Text] [Related]
2. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
3. RNA interference and potential therapeutic applications of short interfering RNAs.
Karagiannis TC; El-Osta A
Cancer Gene Ther; 2005 Oct; 12(10):787-95. PubMed ID: 15891770
[TBL] [Abstract][Full Text] [Related]
4. siRNA-based approaches in cancer therapy.
Devi GR
Cancer Gene Ther; 2006 Sep; 13(9):819-29. PubMed ID: 16424918
[TBL] [Abstract][Full Text] [Related]
5. Short interfering RNAs as a tool for cancer gene therapy.
Izquierdo M
Cancer Gene Ther; 2005 Mar; 12(3):217-27. PubMed ID: 15550938
[TBL] [Abstract][Full Text] [Related]
6. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
7. Delivery of RNA interference to peripheral neurons in vivo using herpes simplex virus.
Anesti AM
Methods Mol Biol; 2010; 617():347-61. PubMed ID: 20336434
[TBL] [Abstract][Full Text] [Related]
8. RNA interference in pain research.
Röhl T; Kurreck J
J Neurochem; 2006 Oct; 99(2):371-80. PubMed ID: 17029593
[TBL] [Abstract][Full Text] [Related]
9. The silent treatment: siRNAs as small molecule drugs.
Dykxhoorn DM; Palliser D; Lieberman J
Gene Ther; 2006 Mar; 13(6):541-52. PubMed ID: 16397510
[TBL] [Abstract][Full Text] [Related]
10. RNA interference in cancer.
Gartel AL; Kandel ES
Biomol Eng; 2006 Mar; 23(1):17-34. PubMed ID: 16466964
[TBL] [Abstract][Full Text] [Related]
11. Review article: RNA interference--potential therapeutic applications for the gastroenterologist.
Pellish RS; Nasir A; Ramratnam B; Moss SF
Aliment Pharmacol Ther; 2008 May; 27(9):715-23. PubMed ID: 18248657
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
13. Antisense and RNAi: powerful tools in drug target discovery and validation.
Lavery KS; King TH
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):561-9. PubMed ID: 12951819
[TBL] [Abstract][Full Text] [Related]
14. RNA interference as a novel and powerful tool in immunopharmacological research.
Kong Y; Ruan L; Ma L; Cui Y; Wang JM; Le Y
Int Immunopharmacol; 2007 Apr; 7(4):417-26. PubMed ID: 17321464
[TBL] [Abstract][Full Text] [Related]
15. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
[TBL] [Abstract][Full Text] [Related]
16. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
17. Using RNAi in the clinic.
Dev KK
IDrugs; 2006 Apr; 9(4):279-82. PubMed ID: 16596482
[TBL] [Abstract][Full Text] [Related]
18. RNA interference: the silent treatment.
Clayton J
Nature; 2004 Sep; 431(7008):599-605. PubMed ID: 15457267
[No Abstract] [Full Text] [Related]
19. [Progression of RNA interference technology and its application in the research of gene function and gene therapy].
Lü H; He ZM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):102-5. PubMed ID: 15871202
[No Abstract] [Full Text] [Related]
20. LNA-antisense rivals siRNA for gene silencing.
Jepsen JS; Wengel J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
